Bisbubstrate inhibitors of kinases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7045617
APP PUB NO 20020031820A1
SERIAL NO

09811870

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Protein kinase inhibitors have applications as anti-cancer therapeutic agents and biological tools in cell signalling. Potent and selective bisubstrate inhibitors for the insulin receptor tyrosine kinase are based on a phosphoryl transfer mechanism involving a dissociative transition state. One such inhibitor is synthesized by linking ATP.gamma.S to a peptide substrate analog via a two-carbon spacer. The compound is a high-affinity competitive inhibitor against both nucleotide and peptide substrate and shows a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirms the key design features inspired by a dissociative transition state, and reveal that the linker takes part in the octahedral coordination of an active site Mg.sup.2+ ion.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOHNS HOPKINS UNIVERISTY111 MARKET PLACE SUITE 906 BALTIMORE MD 21202

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abloogu, Ararat New York, NY 1 0
Cole, Philip A Baltimore, MD 9 90
Courtney, Aliya Baltimore, MD 1 0
Kohanski, Ronald A Fair Lawn, NJ 1 0
Parang, Keykavous Narragansett, RI 20 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation